Prosecution Insights
Prosecution Insights
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (50%) |
| §102 only | 1 (12%) |
| §112 only | 2 (25%) |
| No statute on record | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TINSLEY, BRENDAN THOMAS | 1 | 54.5% | +71.1% |
| RONEY, CELESTE A | 1 | 62.3% | +18.0% |
| MATALKAH, FATIMAH KHALAF | 1 | 56.3% | +11.5% |
| ABBOTT, KODYE LEE | 1 | 52.4% | +62.5% |
| GILL, RACHEL B | 1 | 65.6% | +27.7% |
| TSAY, MARSHA M | 1 | 45.6% | +52.3% |
| NICOL, ALEXANDER W | 1 | 42.0% | +44.9% |
| GRABER, JAMES J | 1 | 46.2% | +56.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759183 | COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS | MATALKAH, FATIMAH KHALAF | 114d overdue |
| 16088693 | CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION | NICOL, ALEXANDER W | 36d overdue |
| 16627227 | AAV VECTOR COLUMN PURIFICATION METHODS | TSAY, MARSHA M | 18d overdue |
| 17862622 | COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS | ABBOTT, KODYE LEE | 15d overdue |
| 18262959 | Compositions and Methods for Treating Hereditary Angioedema | TINSLEY, BRENDAN THOMAS | 9d overdue |
| 15780542 | SCALABLE METHODS FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRAL (AAV) VECTOR IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR CLINICAL USE | GRABER, JAMES J | 22d |
| 18258981 | Methods of Enhancing Non-Viral Gene Therapy | RONEY, CELESTE A | 75d |
| 16631692 | APHERESIS METHODS AND USES | GILL, RACHEL B | — |
| Art Unit | Apps |
|---|---|
| 1634 | 3 |
| 1612 | 1 |
| 1638 | 1 |
| 1671 | 1 |
| 1656 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18262959 | Compositions and Methods for Treating Hereditary Angioedema | TINSLEY, BRENDAN THOMAS | 1634 | §112 | Non-Final OA | 9d overdue | Pending | Jul 26, 2023 |
| 18258981 | Methods of Enhancing Non-Viral Gene Therapy | RONEY, CELESTE A | 1612 | §103 | Non-Final OA | 75d | Pending | Jun 22, 2023 |
| 17759183 | COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS | MATALKAH, FATIMAH KHALAF | 1638 | §103 | Non-Final OA | 114d overdue | Pending | Jul 20, 2022 |
| 17862622 | COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS | ABBOTT, KODYE LEE | 1634 | §112 | Final Rejection | 15d overdue | Pending | Jul 12, 2022 |
| 16631692 | APHERESIS METHODS AND USES | GILL, RACHEL B | 1671 | §102 | Final Rejection | — | Pending | Jan 16, 2020 |
| 16627227 | AAV VECTOR COLUMN PURIFICATION METHODS | TSAY, MARSHA M | 1656 | Other | Non-Final OA | 18d overdue | Pending | Dec 27, 2019 |
| 16088693 | CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION | NICOL, ALEXANDER W | 1634 | §103 | Final Rejection | 36d overdue | Pending | Sep 26, 2018 |
| 15780542 | SCALABLE METHODS FOR PRODUCING RECOMBINANT ADENO-ASSOCIATED VIRAL (AAV) VECTOR IN SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR CLINICAL USE | GRABER, JAMES J | 1631 | §103 | Final Rejection | 22d | Pending | May 31, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial